BioWorld

Oct. 7, 2009

View Archived Issues

Inviragen Risky, SingVax Less: They Marry in Vaccine Heaven

Inviragen LCC and SingVax Pte Ltd. merged their preclinical vaccine pipelines and closed a $15 million Series A financing to tackle infectious diseases affecting emerging markets. (BioWorld Today) Read More

Genentech, SurModics Aiming for Microparticle Version of Lucentis

Read More

JAK Attack Fuels YM, Cytopia Merger; 'Nimo' Spices the Mix

Read More

NewCo News: BioVista's Artificial Intelligence Platform Boosts Drug Discovery

Read More

Clinic Roundup

Read More

Financings Roundup

Read More

Other News To Note

Read More